Here are five takeaways.
1. The laser system is designed to provide advanced MRI-guided laser ablation technology and can be used in neurosurgery procedures.
2. As light is delivered through the applicator, temperatures in the target areas begin to rise, allowing surgeons to destroy unwanted soft tissue.
3. Patients who undergo minimally invasive surgery using the laser system typically return to their homes the following day.
4. Medtronic’s laser system received FDA approval in the U.S. in July 2007 to necrotize or coagulate soft tissue.
5. The company is currently involved in a study in the U.S. to support an expanded FDA indication for the treatment of patients with drug-resistant mesial temporal lobe epilepsy.
More articles on devices and implants:
Stryker shares dip 7.6% in last 3 months: 4 things to know
‘Microjoint’ may postpone hip replacements by a decade or more: 4 insights
Dr. Michael Hisey to present findings from Zimmer Biomet Mobi-C post-hoc analysis — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
